UCLA Semel Institute
Los Angeles, California, 90024, United States
NCT Number: NCT01671436
Major Depressive Disorder (MDD) is a serious, costly and highly prevalent condition. However, currently available treatment options have limited efficacy. The aim of this pilot study is to determine whether patients suffering from MDD who have not responded to at least one antidepressant trial may actively engage in a novel group therapy, Central Meditation and Imagery Therapy (CMIT). Preliminary results with individual patients suggest that CMIT techniques may have benefit for major depression. The purpose of this trial is to assess the feasibility of a group form of CMIT for the treatment of major depression. The trial will also seek to identify neurophysiological and cardiovascular predictors of treatment response.
In this study, 10 subjects with major depressive disorder will receive antidepressant treatment augmentation with group meditation and mental imagery therapy for a total of 12 weeks, as well as daily meditation practice. Group sessions will also involve gentle yogic stretches. The subjects will be limited to those who remain depressed despite at least one trial of antidepressant medication. Changes in brain activity and heart rate variability will be measured at three time points utilizing electroencephalography (EEG) and pulse monitors. Depression symptoms will be measured at several time points using questionnaires and objective measures. Participation will require a total of 15 visits for weekly therapy and the measurements. Two-month follow-up questionnaires will be mailed to the subjects after study end to assess durability of any improvements in depressive symptoms.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Los Angeles, California, 90024, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Measured 4 times over 12 weeks
Primary outcome is change in HAM-D from baseline to Week 12.
Time frame: Weekly assessments measured over 12 weeks, and 2 month follow-up
University of California, San Francisco
Other
Central Meditation and Imagery Therapy for Depression
Acronym: CMIT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00044174
Behavior, Behavioral Symptoms
Bethesda, Maryland, United States
View Trial DetailsNCT05321628
Anxiety Disorders, Behavior
Stockholm, Huddinge, Sweden
View Trial DetailsNCT06993662
Anxiety, Anxiety Disorders
Athens, Greece
View Trial DetailsNCT03851380
Behavior, Behavioral Symptoms
Palo Alto, California, United States
View Trial Details